Development asset linked to TENAX THERAPEUTICS in public FDA and regional records.
pharma · Coronary Artery Bypass Grafting · Hypertension Pulmonary Secondary · TENX
TENAX THERAPEUTICS
TENAX THERAPEUTICS, INC.
TENAX THERAPEUTICS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- Chapel Hill, USA
- Employees
- 19
- Programs
- 7
- Drugs
- 2
- Patents
- 4
TENAX THERAPEUTICS pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
TENAX THERAPEUTICS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to TENAX THERAPEUTICS in public FDA and regional records.